Business Standard

Sandu Pharmaceuticals standalone net profit rises 300.00% in the September 2016 quarter

Image

Capital Market

Sales rise 16.44% to Rs 12.18 crore

Net profit of Sandu Pharmaceuticals rose 300.00% to Rs 0.04 crore in the quarter ended September 2016 as against Rs 0.01 crore during the previous quarter ended September 2015. Sales rose 16.44% to Rs 12.18 crore in the quarter ended September 2016 as against Rs 10.46 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales12.1810.46 16 OPM %5.015.35 -PBDT0.250.16 56 PBT0.060.04 50 NP0.040.01 300

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 15 2016 | 4:54 PM IST

Explore News